Stock Split Candidates: ASML, Eli Lilly, and TransDigm
The stock split wave is back on Wall Street. Following KLA's 10-for-1 split announcement and Booking Holdings' 25-for-1 split, investors are eyeing high-priced stocks like ASML, Eli Lilly, and TransDigm.
Key Numbers
The stock split wave has returned to Wall Street with force. In May 2026, KLA Corporation (NASDAQ: KLAC) announced a 10-for-1 forward stock split, alongside a fiscal Q3 earnings beat and a roughly 21% dividend hike. Its stock was trading around $1,800. Earlier in the year, Booking Holdings (NASDAQ: BKNG) completed a 25-for-1 split announced in February 2026.
These moves raise the question: which big stocks might be next to announce a split? Three prominent candidates are ASML Holding (NASDAQ: ASML), Eli Lilly and Company (NYSE: LLY), and TransDigm Group (NYSE: TDG).
Why Do Companies Split Stocks?
A stock split increases the number of outstanding shares by dividing each share into multiple shares, lowering the price per share without changing the company's market capitalization. The goal is often to make the stock more accessible to retail investors and improve liquidity.
ASML: Semiconductor Giant
ASML trades at high price levels, making it a potential candidate. However, the company has not made any official statements regarding a split.
Eli Lilly: Pharmaceutical Powerhouse
Eli Lilly's stock has risen significantly due to the success of its diabetes and obesity drugs. The high price might prompt management to consider a split, but no confirmed indicators exist.
TransDigm: Defense Components Leader
TransDigm is known for its high stock price and strong margins. A stock split could be a logical step, but the company has not announced any plans.
What This Means for Investors
Stock splits do not change a company's intrinsic value, but they can attract new investors and improve liquidity. Investors should focus on company fundamentals rather than anticipating a split.
Found this useful? Share it